Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José Alberto Sagástegui-Rodríguez"'
Autor:
Maja Relja, Saeed Bohlega, Pedro Chaná, Olga Orlova, Gholam Ali Shahidi, Lingjing Jin, Carlo Colosimo, Roongroj Bhidayasiri, Beomseok Jeon, Ivan Milanov, Dirk Dressler, Federico Micheli, Tae Mo Chung, Sanjay Pandey, Uwe Walter, Fereshte Adib Saberi, Raymond L. Rosales, Sofia Timerbaeva, Eckart Altenmueller, Pedro J. Garcia-Ruiz, Zvezdan Pirtošek, Petr Kanovsky, José Alberto Sagástegui-Rodríguez, Xinhua Wan, Klemens Fheodoroff, Maria Concetta Altavista
Publikováno v:
Journal of Neural Transmission
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by treatment algorithms and injection schemes describing its target muscles and their dosing. Various consensus guidelines have tried to standardise and to improve BT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39741c097ed0142410ccfed81407127c
https://pubmed.ncbi.nlm.nih.gov/33635442
https://pubmed.ncbi.nlm.nih.gov/33635442
Autor:
Carlo Colosimo, Federico Micheli, Petr Kanovsky, Maja Relja, Pedro Chaná, Ryuji Kaji, Dirk Dressler, Raymond L. Rosales, Olga Orlova, Serdar Kocer, Saeed Bohlega, Klemens Fedoroff, Roongroj Bhidayasiri, Bernd Frank, Sebastian Paus, Gholam Ali Shahidi, Hsin Fen Chien, José Alberto Sagástegui-Rodríguez, Markus Ebke, Zvezdan Pirtošek, Paul W. Schoenle, Uwe Walter, Fereshte Adib Saberi, Sofia Timerbaeva, Tae Mo Chung
Publikováno v:
Journal of neurology. 265(4)
Spasticity is a symptom occurring in many neurological conditions including stroke, multiple sclerosis, hypoxic brain damage, traumatic brain injury, tumours and heredodegenerative diseases. It affects large numbers of patients and may cause major di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c760cff35d068e8e20f415333d3ab73
https://pubmed.ncbi.nlm.nih.gov/29423615
https://pubmed.ncbi.nlm.nih.gov/29423615
Autor:
Roongroj Bhidayasiri, Maja Relja, Federico Micheli, Saeed Bohlega, Dirk Dressler, Tae Mo Chung, L. Jorge Jacinto, Olga Orlova, José Alberto Sagástegui-Rodríguez, Markus Ebke, Ryuji Kaji, Raymond L. Rosales, Uwe Walter, Fereshte Adib Saberi, Zvezdan Pirtošek, Abderrahmane Chahidi, Sofia Timerbaeva, Paul W. Schoenle, Serdar Kocer, Gholam Ali Shahidi, Petr Kanovsky, Sebastian Paus
Publikováno v:
Journal of neurology. 264(1)
Botulinum toxin (BT) therapy is an established treatment of spasticity due to stroke. For multiple sclerosis (MS) spasticity this is not the case. IAB-Interdisciplinary Working Group for Movement Disorders formed a task force to explore the use of BT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9cf25f82c4fe60101e63546b89ac28e
https://pubmed.ncbi.nlm.nih.gov/27787630
https://pubmed.ncbi.nlm.nih.gov/27787630